============================================================
QUALITATIVE ERROR ANALYSIS REPORT
Generated on: 2025-08-21 14:53:26
Model: GPT-4o
Dataset: HEP
============================================================

1. BASIC PERFORMANCE METRICS:
   Accuracy: 0.908
   Precision: 0.900
   Sensitivity: 0.917
   F1-Score: 0.908
   Total samples: 2542
   TP: 1165, TN: 1142, FP: 129, FN: 106

2. SMILES COMPLEXITY ANALYSIS:
   False Positives: 129 cases
     Avg combined SMILES length: 103.5 ± 84.8
   False Negatives: 106 cases
     Avg combined SMILES length: 199.8 ± 97.5
   True Positives: 1165 cases
     Avg combined SMILES length: 148.0 ± 67.1
   True Negatives: 1142 cases
     Avg combined SMILES length: 113.6 ± 56.4

3. GENE TARGET COMPLEXITY ANALYSIS:
   False Positives: 129 cases
     Avg combined gene targets: 9.5 ± 17.0
   False Negatives: 106 cases
     Avg combined gene targets: 4.4 ± 3.6
   True Positives: 1165 cases
     Avg combined gene targets: 7.1 ± 8.3
   True Negatives: 1142 cases
     Avg combined gene targets: 5.5 ± 15.2

4. ORGANISM PATTERN ANALYSIS:
   Top false positives organism pairs:
     Humans - Humans: 104 cases
     Humans - Escherichia coli (strain K12): 3 cases
     Enteric bacteria and other eubacteria - Humans: 3 cases
     Humans - Hepatitis C Virus: 2 cases
     Humans - Clostridium perfringens (strain 13 / Type A): 2 cases
   Top false negatives organism pairs:
     Hepatitis C Virus - Humans: 63 cases
     HBV-F - Humans: 17 cases
     Hepatitis C Virus - Escherichia coli (strain K12): 5 cases
     Influenza A virus (strain A/Beijing/11/1956 H1N1) - Humans: 4 cases
     Hepatitis C Virus - Plasmodium falciparum: 3 cases

5. MOST PROBLEMATIC DRUGS:
   Artesunate: 1.000 error rate
     (5/5 errors: 0 FP, 5 FN)
   Acarbose: 1.000 error rate
     (4/4 errors: 0 FP, 4 FN)
   Levocetirizine: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   Goserelin: 1.000 error rate
     (3/3 errors: 1 FP, 2 FN)
   Metformin: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   Thiamine: 1.000 error rate
     (4/4 errors: 0 FP, 4 FN)
   Tiotropium: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   Trimebutine: 1.000 error rate
     (1/1 errors: 0 FP, 1 FN)
   Zanamivir: 1.000 error rate
     (2/2 errors: 0 FP, 2 FN)
   Cyanamide: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)

6. SPECIFIC ERROR EXAMPLES:
   False Positives (predicted interaction, but no real interaction):
     1. Cyanamide + Ixekizumab
        Organisms: Humans - Humans
        Gene targets: 2 - 1
     2. Eptifibatide + Tixagevimab
        Organisms: Humans - SARS-CoV-2
        Gene targets: 3 - 1
     3. Venlafaxine + Copper
        Organisms: Humans - Humans
        Gene targets: 3 - 145
     4. Ibalizumab + Lasmiditan
        Organisms: Humans - Humans
        Gene targets: 3 - 1
     5. Trimetazidine + Baricitinib
        Organisms: Humans - Humans
        Gene targets: 1 - 4
   False Negatives (missed real interactions):
     1. Daclatasvir + Bisacodyl
        Organisms: Hepatitis C Virus - Humans
        Gene targets: 1 - 9
     2. Daclatasvir + Anidulafungin
        Organisms: Hepatitis C Virus - Aspergillus niger (strain CBS 513.88 / FGSC A1513)
        Gene targets: 1 - 1
     3. Daclatasvir + Artesunate
        Organisms: Hepatitis C Virus - Plasmodium falciparum
        Gene targets: 1 - 1
     4. Daclatasvir + Acamprosate
        Organisms: Hepatitis C Virus - Humans
        Gene targets: 1 - 9
     5. Daclatasvir + Acarbose
        Organisms: Hepatitis C Virus - Humans
        Gene targets: 1 - 4

7. SUMMARY INSIGHTS:
   - Model tends to over-predict interactions (more false positives than false negatives)
   - High sensitivity but lower precision - good at catching interactions but with some false alarms

Report generation completed successfully.
============================================================
